A Multicenter, Randomized, Double Blind Study to Compare the Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (Janumet) Compared to Glimepiride in Patients With Type 2 Diabetes Mellitus
Phase of Trial: Phase IV
Latest Information Update: 03 Oct 2017
At a glance
- Drugs Metformin/sitagliptin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 10 Jun 2017 Biomarkers information updated
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 01 Oct 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.